Company chart and information is provided by TradingView based on 15-minute-delayed data.
FSD Pharma Inc, through its wholly-owned subsidiary, is focused on Pharmaceutical research and development of its lead compound, FSD 201, ultra-micronized Palmitoyl ethylamine. The FSD 201 is known to stabilize mast cells of the human body and down-regulate the proinflammatory cytokines to effectuate an anti-inflammatory response.
| Website: | www.fsdpharma.com |
| Main Phone: | +1 647 864-7969 |
| Address: | 100 King Street West |
| Address 2: | Suite 3400 |
| State: | ON |
| City / Town: | Toronto |
| Country: | CA |
| Postal Code: | M5X 1A4 |
| Exchange: | NSC |
| CEO: | Ron Downey |
| Employees: | 9 |
| NAICS: | Pharmaceutical Preparation Manufacturing(325412) |
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2022 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
